Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.21.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities    
Net loss $ (5,195) $ (7,578)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 31 42
Share-based compensation expense 581 633
Change in fair value of warrant liabilities (5,567) (416)
Net amortization of premium (discount) on marketable securities 150 (7)
Changes in operating assets and liabilities:    
(Increase) decrease in prepaid expenses and other current and non-current assets (936) 934
Increase (decrease) in accounts payable, accrued liabilities and other liabilities 1,877 (1,157)
Net cash used in operating activities (9,059) (7,549)
Cash flows from investing activities    
Purchases of marketable securities   (9,999)
Proceeds from sales of marketable securities 4,913 3,996
Net cash provided by (used in) investing activities 4,913 (6,003)
Cash flows from financing activities    
Proceeds from issuance of securities 57,500  
Payment of financing costs of securities sold (3,703)  
Proceeds from the exercise of warrants 110  
Net cash provided by financing activities 53,907 0
Net increase (decrease) in cash and cash equivalents 49,761 (13,552)
Cash and cash equivalents at beginning of period 15,485 24,184
Cash and cash equivalents at end of period $ 65,246 $ 10,632